Evidence map›Paper›PMID 34115555›Full record

ArticleBioengineered2021

MicroRNA miR-126 attenuates brain injury in septic rats via NF-κB signaling pathway.

Anna Nong, Qingfeng Li, Zhijing Huang, Yunan Xu, Kebin He, Yuying Jia, Zhenyi Cen, Lianghua Liao, Yueyan Huang

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. MicroRNA-126 as an endogenous molecule for hypoxic/ischemic tolerance in neuroprotection.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. MicroRNA-126 (MiR-126): key roles in related diseases.Journal of physiology and biochemistry · 2024
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Anna NongGraduate School, Youjiang Medical University for Nationalities, Baise, Guangxi China.
Qingfeng LiDepartment of Radiology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi China.
Zhijing HuangDepartment of Pediatric Internal Medicine Ward 1, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi China.
Yunan XuGraduate School, Youjiang Medical University for Nationalities, Baise, Guangxi China.
Kebin HeGraduate School, Youjiang Medical University for Nationalities, Baise, Guangxi China.
Yuying JiaGraduate School, Youjiang Medical University for Nationalities, Baise, Guangxi China.
Zhenyi CenGraduate School, Youjiang Medical University for Nationalities, Baise, Guangxi China.
Lianghua LiaoGraduate School, Youjiang Medical University for Nationalities, Baise, Guangxi China.
Yueyan HuangDepartment of Radiology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, Guangxi China.
Affiliated Hospital of Youjiang Medical University for Nationalities · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The purpose of this study was to investigate the impact and mechanism of microRNA miR-126 on brain injury induced by blood-brain barrier (BBB) damage in septic rats. We used cecal ligation and perforation (CLP) to create a rat model of sepsis. The experimental rats were randomly divided into Control group, CLP group, CLP + miR-NC group, CLP + miR-126 group and CLP + miR-126 + NF-κB pathway agonist (PMA) group. MiR-126 expressed in the brain tissue of CLP rats was down-regulated by qRT-PCR. Upregulation of miR-126 in CLP rats could improve brain injury and BBB marker protein level, reduce brain water content, Evans blue extravasation, inflammation, and excessive oxidative stress. This could also result in an inhibition of NF-κB signaling pathway activity. In conclusion, miR-126 overexpression can prevent brain injury caused by BBB damage via the inhibition of NF-κB signaling pathway activity.

Indexed as

SepsisAnimalsBlood-Brain BarrierBrain DiseasesMaleMicroRNAsNF-kappa BRatsRats, Sprague-DawleySignal TransductionMicroRNAsMIRN126 microRNA, ratNF-kappa Bblood-brain barrierbrain injurymiR-126nf-κB signaling pathwaySepsis

Identifiers

PMID34115555
PMCPMC8806573
OpenAlexW3169713332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.